januvia glp 1 for Type 2 Diabetes Demise of Merck's weekly DPP-4

As shown in Table 4 , liraglutide had the strongest association with AKI by ROR and BCPNN, followed by semaglutide and lixisenatide

It is synthesised in the body from the amino acids lysine and methionine, primarily in the liver and kidneys, and is also obtained through dietary sources such as red meat, fish, and dairy products

Administration Challenges: Compounded GLP-1 agonists are typically dispensed in multi-dose vials, requiring more skill and training for proper administration compared to the pen devices used for commercial products

Gradual dose reduction over 4-8 weeks helps minimize withdrawal-like effects including appetite rebound and rapid weight regain